Table 3. Medicines reported out of stock during the three months prior to contact in South African facilities.
| Name and formulation of medicine | Number of reported stock-outs (%)* | Name and formulation of medicine | Number of reported stock-outs (%)* |
|---|---|---|---|
| (LPV/r) Lopinavir/Ritonavir 200mg/50mg, tablet | 348 (24%) | (EFV) Efavirenz 50mg, tablet | 14 (1%) |
| (ABC) Abacavir 600mg, tablet | 278 (19%) | (R/H) Rifampicin/Isoniazid 300/150mg, tablet | 14 (1%) |
| (3TC) Lamivudine 150 or 300 mg, tablet | 197 (13%) | (RHZE) Rifampicin/Isoniazid /Pyrazinamide/Ethambutol 150/75/400/275mg, tablet | 12 (0.8%) |
| (AZT) Zidovudine 300mg, tablet | 72 (5%) | (TDF/FTC) Tenofovir/ Emtricitabine 300/200mg, tablet | 9 (0.6%) |
| (ABC) Abacavir 60mg tablet or 20mg/ml solution | 71 (5%) | (R/H) Rifampicine/Isoniazid 60/60mg, tablet | 9 (0.6%) |
| TDF/FTC/EFV Tenofovir/Emtricitabine/Efavirenz 300/200/600mg, tablet | 62 (4%) | (RTV) Ritonavir 100mg, tablet | 8 (0.5%) |
| (LPV/r) Lopinavir/Ritonavir 80/20mg/ml, solution | 57 (4%) | (D4T) Stavudine 30mg, tablet | 7 (0.5%) |
| (LPV/r) Lopinavir/Ritonavir 100/25mg, tablet | 36 (2%) | (D4T) Stavudine 15mg or 20 mg, tablet | 7 (0.5%) |
| (EFV) Efavirenz 200mg, tablet | 30 (2%) | (ABC/3TC) Abacavir/Lamivudine 600/300mg, tablet | 6 (0.4%) |
| (NVP) Nevirapine 50mg/50ml, solution | 27 (2%) | (AZT) Zidovudine solution 50mg/5ml | 6 (0.4%) |
| (EFV) Efavirenz 600mg, tablet | 26 (2%) | (E) Ethambutol 400mg, tablet | 5 (0.3%) |
| (NVP) Nevirapine 200mg, tablet | 26 (2%) | (R) Rifampicin 300mg, capsule | 5 (0.3%) |
| (DDi) Didanosine, tablet | 21 (1%) | (PZA) Pyrazinamide 150mg, tablet | 4 (0.3%) |
| (3TC) Lamivudine 10mg/ml solution | 21 (1%) | (PZA) Pyrazinamide 500mg, tablet | 4 (0.3%) |
| (INH) Isoniazid 300mg, tablet | 21 (1%) | (Lvx) Levofloxacin 250 or 500mg, tablet | 4 (0.3%) |
| (R/H) Rifampicin/Isoniazid 150/75mg, tablet | 18 (1%) | (RTV) Ritonavir 80mg/ml, solution | 3 (0.2%) |
| (TDF) Tenofovir 300mg, tablet | 15 (1%) | Other | 10 (0.7%) |
| (AZT) Zidovudine 100mg, tablet | 14 (1%) |
* Percentages are number of reported stock-outs for individual medicine divided by total number of reported stock-outs (1475)